Australia Household Impacts of Covid-19 Survey March 2022
Survey:
Household - Individual - Interview - Longitudinal - Nationally representative
Medical tests
Dataset Records for Medical tests
Displaying 1 - 50 of 1070
Thailand Malaria Elimination Program - GMS Malaria 2022
Epi surveillance:
Subnationally representative
Peru Demographic and Family Health Survey 2022
Encuesta Demográfica y de Salud Familiar (ENDES) 2022
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Guinea Malaria Indicator Survey 2021
République de Guinée Enquête sur les Indicateurs du Paludisme et de l’Anémie en Guinée (EIPAG) 2021
Survey:
Cross-sectional - GPS coordinates (GIS) - Household - Individual - Nationally representative - Subnationally representative - Urban-rural representative
Premise Malaria COVID-19 Health Services Disruption Survey 2021
Survey:
Cross-sectional - Individual
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint
GHDx Entry last modified on: Sep 13, 2022
El Salvador National Health Survey 2021
Encuesta Nacional de Salud (ENS), El Salvador 2021; ENS 2021
Survey:
Cross-sectional - Household - Nationally representative - Subnationally representative - Urban-rural representative
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase
Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021.
Survey:
Epi surveillance
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Portugal National Serological Survey COVID-19 (2nd phase) 2021
Inquérito Serológico Nacional COVID-19 (2.ª fase) (INS COVID-19)
Survey:
Individual
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint
GHDx Entry last modified on: Mar 14, 2022
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint
GHDx Entry last modified on: Mar 14, 2022
Thailand Malaria Elimination Program - GMS Malaria 2021
Epi surveillance:
Subnationally representative
United States National Health Interview Survey 2021
2021 NHIS
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative
Brazil Live Birth Information System SINASC 2021
Sistema de Informações Sobre Nascidos Vivos
Vital registration:
Subnationally representative
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Yemen Supreme National Emergency Committee for COVID-19 Daily Report 2021
GHDx Entry last modified on: Aug 24, 2023
United States Behavioral Risk Factor Surveillance System 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative
United States COVID Tracking Project 2021
The COVID Tracking Project at The Atlantic
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint
GHDx Entry last modified on: May 12, 2022
Peru Demographic and Family Health Survey 2021
Encuesta Demográfica y de Salud Familiar (ENDES) 2021
Survey:
Cross-sectional - Household - Individual - Interview - Nationally representative - Subnationally representative - Urban-rural representative
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: May 12, 2022
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
Canada - British Columbia COVID-19 Situation Report 2020-2022
British Columbia (BC) COVID-19 Situation Report
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Population-based seroprevalence of SARS-CoV-2 antibodies in a high-altitude setting in Peru. Preprint
GHDx Entry last modified on: May 12, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest
Survey:
Cross-sectional - Epi surveillance - Urban only
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Mexico - Yucatán Under-5 Endline Household Survey 2020
Survey:
Cross-sectional - Household - Individual - Interview
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Sero-pravelence of SARS CoV-2 IgM and IgG Antibodies Amongst Blood Donors in Nigeria. Preprint
Scientific literature:
Epi surveillance
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
About 10 million people have been infected with the Corona virus in Afghanistan
حدود ده ملیون تن در افغانستان به ویروس کرونا مبتلا شده اند
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Press Briefing: Sero Survey Delhi
Survey:
Cross-sectional - Urban only
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey
Survey:
Urban only
29.1% people in Delhi developed antibodies against COVID-19, finds latest sero-survey
GHDx Entry last modified on: Aug 1, 2022
Subscribe